The Playground

    India's vaccine only death cult state still leads all death statistics.

    COVID-19: 4,801 cases in Kerala on Wednesday, TPR rises to 6.75%
    With the Omicron variant spreading rapidly, cases have been increasing and the active cases again crossed the 20K-mark.COVID-19 cases in Kerala. Coronavirus in…
    www.onmanorama.com

    They just did dig out more than 200 "hidden deaths but official report 400..." and go on with spoiling India data.


    But Omicron cases are strongly raising in all states and now seem to take off! The impact on deaths will be seen within 2 weeks earliest.


    Newspaper: https://indianexpress.com/arti…coronavirus-news-7705006/

    5th January::


    India records first Omicron death in Rajasthan's Udaipur

    India on Wednesday recorded the first death linked to the Omicron variant of the coronavirus after the samples of a man in Rajasthan's Udaipur, who died last week, showed the presence of the variant, sources in the Union health ministry said.


    The 73-year-old man, who was found infected with Omicron in genome sequencing and who had tested negative for the infection twice, died in a Udaipur hospital on December 31, they added.


    He died due to post-Covid pneumonia coupled with comorbidities -- diabetes mellitus, hypertension and hypothyroidism -- Udaipur Chief Medical Health Officer (CMHO) Dr Dinesh Kharadi had said. (PTI)


    Tested twice negative... very strange...

    May not mean a thing but then again...... You are funny, don't go backwards

    CDC’s Director Inquired into Deceased 13-Year-Old Boy Just Two Days After Vaccination


    CDC’s Director Inquired into Deceased 13-Year-Old Boy Just Two Days After Vaccination
    A conservative watchdog group accessed 314 pages of Centers for Disease Control and Prevention (CDC) records, indicating the federal public health
    trialsitenews.com


    A conservative watchdog group accessed 314 pages of Centers for Disease Control and Prevention (CDC) records, indicating the federal public health agency’s director was concerned about a possible COVID-19 vaccine-related death. The Judicial Watch secured a trove of documents via a Freedom of Information Act (FOIA) request that reveals Rochelle Walensky issued a request to uncover more details about a teenager who died after receiving the COVID-19 vaccine.


    An article titled, “CDC reportedly probing Michigan teen’s death after COVID-19 vaccination” on June 28 apparently got the attention of the top federal bureaucrat, as she sent a communication to Dr. Henry Walke, director of CDC’s Division of Preparedness and Emerging Infections, who received the request from the director declaring “Any details on this?” The email found its way to another CDC executive, David Fitter who answered, “The case had been reported to VAERS [CDC’s Vaccine Adverse Event Reporting System]. CDC has spoken with ME [Medical Examiner], but we are following protocol for f/u [follow-up] re the case. Additionally, CDC remains in contact with MI to assist in the investigation,” as reported by Judicial Watch.


    Investigation

    The FOIA documentation reveals that another CDC official named Jennifer Layden followed up on this communication thread, noting the case was working its way through VAERS and their internal review process.


    What happened to the deceased?

    The deceased is a 13-year-old healthy boy with no apparent medical history. Two days after he was vaccinated, the boy was found “unresponsive.” The only sign of any health trouble had been a fever, but nothing else was noticeably wrong.



    The initial pathologist report points to “bilateral ventricular enlargement and histology consistent with myocarditis,” but these are preliminary findings.


    CDC Safety Team Status—Nothing Urgent?

    In response, a CDC safety team email revealed that “CDC is not actively involved in this investigation (i.e., IDPB examining specimens). The representative from the safety team communicated that the matter was underway with a state health department and pathologist who performed an autopsy and they “are in touch to maintain situational awareness.”


    The CDC appears to be communicating that the whole investigation is in limbo, declaring, “The autopsy was completed when we contacted the state health department and no request for CDC assistance has been made.”


    So now that an autopsy report is pending finality, the CDC and the state health department communicate about the case while its remains under investigation.


    Clinical Trial Discussions: ADE

    The Judicial Watch cache also highlights an email between Christie Blomquist, AstraZeneca’s vice president for corporate affairs, North America and Walensky. The former sent the latter a press release stating that “The reduced Fc receptor binding aims to minimize the risk of antibody-dependent enhancement of disease – a phenomenon in which virus-specific antibodies promote, rather than inhibit, infection and/or disease.”


    By July 26, 2021, Judicial Watch shared also that Walensky received study information via email from a redacted person titled “Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine.” This study included 44,165 randomized participants. The unknown email sender declared “Of these participants, 44,060 were vaccinated with 2:1 dose (BNT162b2, n=22,030; placebo, n=22,030), and 98% received dose 2 (Fig.l). During the blinded period, 51% of participants in each group had 4 to <6 months of follow-up post-dose 2; 8% of BNT162b2 recipients and 6% of placebo recipients had 2:6 months follow-up post-dose 2.”


    What about AEs?

    The email communication concerning the Pfizer mRNA study revealed, “Adverse event analyses during the blinded period are provided for 43,847 2:16-year-olds (Table S3). Reactogenicity events among participants not in the reactogenicity subset are reported as adverse events, resulting in imbalances in adverse events (30% vs 14%), related adverse events (24% vs 6%), and severe adverse events (1.2% vs 0.7%) between BNT162b2 and placebo groups.”


    Moreover, the Judicial Watch press release reveals the CDC discussed new adverse events such as “Decreased appetite, lethargy, asthenia, malaise, night sweats, and hyperhidrosis.”


    TrialSite’s Sonia Elijah recently reported on some concerning safety information associated with the Pfizer vaccine and another cache of documents via FOIA. The BMJ reported that a whistleblower alleged that a contract research organization involved with the BNT162b2 clinical trial was involved with quality control problems and possibly data manipulation issues. Senior editors from The BMJ had to write a complaint to Mark Zuckerberg after Facebook fact-checkers made that story disappear.


    What is Judicial Watch?

    A conservative activist group, Judicial Watch was originally organized to go after corruption and waste at the federal level of government. It was initially targeted to go after Democrats in 1994, with a particular focus on then-President Bill Clinton.


    The organization is known to be heavily biased against Democratic operatives versus corrupt Republicans which they seem to not investigate much. The group is known for FOIA efforts combined with lawsuits. They deny global warming and align with several other controversial positions. Regardless, activist groups demanding more federal transparency, considering the pandemic, federal mandates, safety concerns, and the like are important regardless of political ideology at this stage.


    CDC Risks of Covid Vaccines November 2021 - Judicial Watch
    www.judicialwatch.org

    Quote from Fm1

    Climatic signatures in the different COVID-19 pandemic waves across both hemispheres

    For crying out loud! Are you incapable of even the simplest analysis??? That data is from March to October 2020. There were no vaccines then. Obviously, climate and other factors dominated in the absence of vaccines. Once the vaccines were introduced, in all climates and all nations they drastically reduced cases and deaths. The effect of vaccines was much larger than other factors such as climate.


    No one disputes that climate has an effect on respiratory diseases. But it does not lower cases by 99% in a few months, and then keep it down from summer to January, which is what you see in Japan. The climate there changed from summer to winter, but the number of cases did not increase.


    Quote from Fm1

    You miss the point. Vaccination rates look wonderful in the summer months, not so much in winter.

    That is completely false. Look at the data for Japan. The peak was in August, from delta. It fell to nothing and stayed there, through December until this week with omicron. The only reason it fell was because of the vaccines.


    Japan: the latest coronavirus counts, charts and maps
    Tracking the COVID-19 outbreak, updated daily
    graphics.reuters.com

    Here's Japan's current ethical position on vaccination status :

    Quote from Mark U

    Please do not force anyone in your workplace or those who around you to be vaccinated, and do not discriminate against those who have not been vaccinated.

    In contrast, a video of Canada's Prime Minister speaking in September 2021 about the unvaccinated has resurfaced. Justin Trudeau seems to speak his true mind more when he speaks French, rather than English.


    Clip resurfaces of Trudeau calling unvaccinated “extremists, misogynists, racists”
    In the Sep. 16, 2021 interview which aired on the French-language program La semaine des 4 Julie, Trudeau referred to unvaccinated Canadians as “extremists,”…
    tnc.news


    “Yes, we will get out of this pandemic by vaccination. We all know people who are a little bit hesitant. We will continue to try and convince them, but there are also people who are fiercely against vaccination,” said Trudeau.

    “They are [host : extremists ] who don’t believe in science, they’re often misogynists, also often racists. It’s a small group that muscles in, and we have to make a choice in terms of leaders, in terms of the country. Do we tolerate these people?

    Or do we say, hey, most of the Quebecois people – 80% – are vaccinated. We want to come back to things we like doing. It’s not those people who are blocking us.”


    Those who speak like the above seem almost always to be double vaccinated. I've heard it called the Covid Karen syndrome. It is very unfortunate that our Prime Minister in particular has this condition, because he has a large influence. I've seen more extreme presentations of the condition in other videos, showing Covid Karens removing their masks to swear, hit and spit in the faces of the unmasked. There is no known antidote to this condition.


    I was pleased to see that Neil Oliver at Great Britain (GB) News caught wind of the Trudeau video and said that he thought the incitement from Trudeau was 'borderline criminal".


    External Content www.youtube.com
    Content embedded from external sources will not be displayed without your consent.
    Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.

    The small upper RH circuit board in the SKlep electronics group is also on top of the pyramidal device (Prototype 1). It resembles a remote control rgb led dmx decoder/amplifier crossed with a constant current dc drop down regulator. It might have had a function in Prototype 1.
    I haven’t seen a match on the internet yet but not exactly sure what I’m looking for.

    Quote from Wyttenbach

    Quite nonsense: India in average grows 20%/day. But with low case values in the 0.0001% population region you cannot make any prediction.

    How many persons do daily change border in a 230'000'000 state? We had the same problem with 200 ICU cases from Kosovo,Serbia etc.. So we have to wait at least one more week to get reliable data.


    In the low case region deaths are more reliable for growth. Uttar Pradesh just had the first one since a very long time. And Kerala did only dump a few old ones. So the overall death figure is cheating a down turn...

    Still exponential… meanwhile ca. 40% of Kerale new infections…

    Quote from Wyttenbach

    Trends are never inside noise. This is a contradiction in terminology.

    Apologies to everyone for these geekish corrections. Nothing really to do with this thread. I do it just because I have this idea that everyone here is capable of not getting internal logic/stats wrong. I know some will believe all data sources are corruptly manipulated and therefore the world is different from what appears - obviously if somone things that they can quite consistently believe almost anything.


    Not sure if this is an attempt to mislead or whether W really don't understand.


    When detecting trends you have a limited time series of data, with each point having some randomness.


    If the time series is too short (as here - you were claiming a trend over 2 weeks) the noise in the data will swamp all trends up to some given slope determined by the time series length and the magnitude of the noise. In this case we say "the (claimed) trend is inside the noise".


    In this case because the data (numbers of active severe illnesses in vaccinated people) comes from on average 0.5 people per week the randomness inherent in that quantisation (you cannot have half a person severely ill) swamps any trend.


    I posted the graph showing the number of new illnesses (and are argument does not depend on how nserious - you were saying the cumulative graph shows a concerning trend - I pointed out that on investigation it was inside the noise).


    The sad thing is that there will be trends in this data, and they could be concerning. But claiming as a trend something that is very exaggerated and anomalous should - it did me - make you pause and check is what antivaxxers (who basically argue from the result they want and make all evidence fit it) do. I'm sure everyone on this thread posting now would not be like that.


    THH

    Quote from Alan Smith



    We'll soon see what happens when it's colder and damper -lots of snow in Tokyo yesterday.

    Yes, I wonder has Tokyo done anything to improve indoor ventilation in offices and schools... That was one of the big failing of the UK government. The health and safety advice still emphasises sanitiser and says vague things about (expensive) ventilation. No money was provided to install ventilation.


    We had one year to put this right - it was not done. But Japan? i don't know...

    Quote from JedRothwell

    For crying out loud! Are you incapable of even the simplest analysis??? That data is from March to October 2020. There were no vaccines then. Obviously, climate and other factors dominated in the absence of vaccines. Once the vaccines were introduced, in all climates and all nations they drastically reduced cases and deaths. The effect of vaccines was much larger than other factors such as climate.


    No one disputes that climate has an effect on respiratory diseases. But it does not lower cases by 99% in a few months, and then keep it down from summer to January, which is what you see in Japan. The climate there changed from summer to winter, but the number of cases did not increase.

    It is interesting (and not much done because difficult) to estimate the effect on R0 of various things.


    For omicron (where vaccines are least effective against infection and transmission - even though they do a better job (thank God) against serious disease) RB (thanks) posted some data from Denmark about household transmission showing 50% less after booster vaccination.


    So that is an R reduction of 50%. For delta it would have been more, maybe 80% reduction. The protection from infection of the vaccines is time dependent (as is survivor's immunity protection against infection). So that 80% delta would go down to 50% after maybe 6 months etc.


    You can see that form original -> alpha -> delta -> omicron we have two effects:


    (1) The "no intervention" R0 value gets higher. Guess, and depends on mnay other factors like season and type of ventilation, but something like:


    2.5 - original

    3.5 - alpha

    6 - delta


    (2) Vaccination reduces R0 according to fraction of population vaccinated and how much vaccination reduces transmission. Again, guesstimates but vaguely correct:


    X 0.1 - original

    X 0.13 - alpha

    X 0.17 - delta

    X 0.5 - omicron


    To show the effect of the unvaccinated on epidemic spread of omicron for a fraction U unvaccinated (0 < U < 1) that 0.5 factor would become (U + 0.5(U-1)) = 1.5U - 1. This is the factor that antivaxxer propaganda influences (whereas the personal cost - which is larger - come from the higher disease and death rates for the unvaccinated).


    Obviously it matters less than for delta - because original COVID formulation vaccines are less effective against infection against a variant so far away.


    One of the things not talked about is when do we expect to get better vaccines. It is not clear. There is nothing technically impossible about making them - it comes down to politics and money.


    (3) seasonality factors change R, maybe by between 1.2 (winter) and 0.8 (Summer). That is a big guess. Somone could look up some real estimates though I think they are pretty variable.


    (4) social distancing, mask wearing, other interventions all contribute another factor reducing R if used. Maybe between 1 (no NPI) to 0.5 (maximum non-lockdown NPI to 0.2 (full lockdown NPI).


    (5) COVID survivor's immunity contributes another factor once enough people have had COVID. Note that although asymptomatic COVID accounts for maybe 40% of delta cases and probably more omicron, the immunity from mild infection is less than that got from symptomatic infection. this is the factor least understood. When I've done calculations for the UK, it takes a lot of cases and deaths to get survivor's immunity up to something like 50% of population. This factor then works like vaccination. If the fraction with survivor's immunity is S, the overall reduction will be maybe (S + 0.2(S-1) where 0.2 is the reduction in infection due to survivor's immunity. That depends on which variant you have survived - although omicron is so far away from other variants that figure is probably more like 0.5 for omicron from any previous variant COVID infection. Survivor's immunity also wanes over time. Slower than vaccine immunity. As with vaccination, the protection against severe disease from survivor's immunity is better than from infection.


    The protection survivor's immunity offers against death is particularly good! Why? Because survivors are those who did not die first time round, and their immune systems will be better able to cope with the virus second time so they certainty ought to survive! A lot of survive or no is genetic luck of the draw. (Aryan super-races do not, thankfully, fare better than anyone else in this). Anyway that is not relevant to R0 and whether the pandemic spreads, though it is important personally.


    Multiply them all together and you get an overall R value. If > 1 - you get an epidemic wave. If < 1, any infection dies out.


    The public discussion, because it does not lay out all these (guessed) numbers can easily be misleading.


    Take home? What matters (quantitatively) most is variant and vaccine until a lot of people have caught COVID - then survivor's immunity as also important. Both vaccine and survivor's immunity are complex and depend on other factors, so which matters more (in calculating R) is not simple and will change.


    THH

    Quote from THHuxleynew

    Yes, I wonder has Tokyo done anything to improve indoor ventilation in offices and schools... That was one of the big failing of the UK government. The health and safety advice still emphasises sanitiser and says vague things about (expensive) ventilation. No money was provided to install ventilation.


    We had one year to put this right - it was not done. But Japan? i don't know...

    Virtually every indoor space in and around the cities including most homes has aircon. So it's hard to tell.

    CDC Survey of 6 Hospitals During Delta: Child Hospitalization Increases Especially Among Black & Latinos & Obese


    CDC Survey of 6 Hospitals During Delta: Child Hospitalization Increases Especially Among Black & Latinos & Obese
    Recently, the U.S. Centers for Disease Control and Prevention (CDC) issued their “Morbidity and Mortality Weekly Report (MMWR)” reporting that while the
    trialsitenews.com


    Recently, the U.S. Centers for Disease Control and Prevention (CDC) issued their “Morbidity and Mortality Weekly Report (MMWR)” reporting that while the Omicron variant of SARS-CoV-2 represents the fastest-growing cause of infections. The also highly transmissible Delta variant is the cause of an increase in the number of children hospitalized with COVID-19. Based on an ongoing survey of data of hospitalized children across six hospitals, from July-August 2021, 77.9% of those children were admitted for acute COVID-19. About 33% of the patients aged <5 years were diagnosed with a viral coinfection (about two-thirds of which were respiratory syncytial virus), while the majority (61%) of young people 12 to 17 years old had obesity. Importantly, of all the hospitalized age-eligible patients, only 0.4% were vaccinated. The CDC’s point here is to remind parents that at least a few months ago, unvaccinated children at these representative hospitals faced higher risks for hospitalization.


    The following is a brief TrialSite breakdown of this report.


    When did the Delta variant emerge as a dominant challenge?

    During the period of evaluation (July-August 2021), the highly transmissible and infectious Delta variant represents the predominant circulating strain in America.


    How many patients did the CDC review?

    915 patients



    How many were hospitalized for COVID-19 (acute COVID-19 infection as the primary contributing reason for hospitalization)?

    713 (77.9%) were hospitalized for COVID-19 as the primary reason for hospitalization. 177 (19.3% were reported to have had incidental positive SARS-CoV-2 test results (asymptomatic or mild infection unrelated to the reason for hospitalization); 25 (2.7%) were reported diagnosed with multisystem inflammatory syndrome in children (MIS-C), a rare but serious inflammatory condition that’s known to accompany COVID-19.


    What were the age cohorts among the hospitalized?

    Of the 713 hospitalized for COVID-19, see the following:


    Age Cohort % Total

    <1 year 24.7

    1-4 year 17.1

    5-11 20.1

    12-17 38.1

    How many of the hospitalized children had one or more underlying condition?

    67.5%


    What was the most common underlying condition?

    Obesity at 32.4% across all age groups


    What about obesity in the age range of 12-17 years?

    61.4% (And 60% had what is classified as severe obesity)


    What about a sex and ethnic minority breakdown of hospitalized?

    Out of 713 patients hospitalized of COVID-19:


    Category % Hospitalized

    Male 52.3

    White 29.5

    Black 28.4

    Hispanic 29.6

    TrialSite notes that these figures are overrepresented by minority groups. For example, the United States is 12.1% Black and about 20% Hispanic. Clearly, the young, potentially poor ethnic minorities face higher COVID-19 infection hospitalization risks.


    What about viral coinfection?

    According to the CDC report:


    15.8% of the total had viral coinfection

    66.4% of the above had RSV infection

    33.9% of patients less than 5 years of age who were hospitalized for COVID-19 had a viral coinfection.

    What were the details of their hospitalizations?

    Out of 915 patients, 713(77.9%) were hospitalized for COVID-19. Among 272 vaccine-eligible (aged 12–17 years) patients hospitalized for COVID-19, one (0.4%) was fully vaccinated. Approximately one-half (54.0%) of patients hospitalized for COVID-19 received oxygen support, 29.5% were admitted to the intensive care unit (ICU), and 1.5% died; of those requiring respiratory support, 14.5% required invasive mechanical ventilation (IMV).


    Many of these pediatric patients with COVID-19–related hospitalizations had severe illness and viral coinfections, and few vaccine-eligible patients hospitalized for COVID-19 were vaccinated, highlighting the importance of vaccination for those aged ≥5 years and other prevention strategies to protect children and adolescents from COVID-19, particularly those with underlying medical conditions.


    What did the CDC define as fully vaccinated?

    Fully vaccinated was defined as having received 2 doses of an mRNA-based COVID-19 vaccine ≥14 days before the hospital admission date. Partially vaccinated was defined as having received only 1 dose of an mRNA-based COVID-19 vaccine ≥14 days before hospitalization. All vaccinated patients in this study received the Pfizer-BioNTech (BNT162b2) vaccine


    Characteristics and Clinical Outcomes ...
    This report describes outcomes of children and adolescents <18 Years Hospitalized with COVID-19.
    www.cdc.gov

    This helps explain the vaccine strategy in the United States. $$$$$$$. If it ain't the latest, greatest and most expensive, take it somewhere else


    When a new strain of coronavirus triggered the COVID-19 pandemic, Hotez and Bottazzi figured they could dust off their old technology and modify it for use against COVID-19. After all, the virus causing COVID-19 and the virus causing SARS are quite similar.

    Hotez says they tried to interest government officials in the vaccine, but they weren't impressed.



    A Texas team comes up with a COVID vaccine that could be a global game changer


    NPR Cookie Consent and Choices


    A vaccine authorized in December for use in India may help solve one of the most vexing problems in global public health: How to supply lower-income countries with a COVID-19 vaccine that is safe, effective and affordable.


    The vaccine is called CORBEVAX. It uses old but proven vaccine technology and can be manufactured far more easily than most, if not all, of the COVID-19 vaccines in use today.


    "CORBEVAX is a game changer," says Dr. Keith Martin, executive director of the Consortium of Universities for Global Health in Washington, D.C. "It's going to enable countries around the world, particularly low-income countries, to be able to produce these vaccines and distribute them in a way that's going to affordable, effective and safe."


    The story of CORBEVAX begins some two decades ago. Peter Hotez and Maria Elena Bottazzi were medical researchers at George Washington University in Washington, D.C., where they worked on vaccines and treatments for what are called neglected tropical diseases, such as schistosomiasis and hookworm.


    When a strain of coronavirus known as SARS broke out in 2003, they decided to tackle that disease. After moving to Houston to affiliate with Baylor College of Medicine and the Texas Children's Center for Vaccine Development, they created a vaccine candidate using protein subunit technology. This involves using proteins from a virus or bacterium that can induce an immune response but not cause disease.

    It's the same technology as the hepatitis B vaccine that's been around for decades," Hotez says.


    The goal: at least 40% vaxxed in all nations by year-end. This map shows how we stand


    The goal: at least 40% vaxxed in all nations by year-end. This map shows how we stand

    Their SARS vaccine candidate looked promising, but then the SARS outbreak petered out. No evidence of disease, no need for a vaccine.


    When a new strain of coronavirus triggered the COVID-19 pandemic, Hotez and Bottazzi figured they could dust off their old technology and modify it for use against COVID-19. After all, the virus causing COVID-19 and the virus causing SARS are quite similar.


    Hotez says they tried to interest government officials in the vaccine, but they weren't impressed.


    "People were so fixated on innovation that nobody thought, 'Hey, maybe we could use a low-cost, durable, easy-breezy vaccine that can vaccinate the whole world,' " Hotez says.


    "We really honestly couldn't get any traction in the U.S., but our mission is always to enable technologies for low- and middle-income countries production and use," Bottazzi recalls.


    So they turned to private philanthropies. A major donor early on was the JPB Foundation in New York.


    "The rest were all Texas philanthropies: the Kleberg Foundation, the [John S.] Dunn Foundation, Tito's Vodka," Hotez says. The MD Anderson Foundation also chipped in.


    "When people say, 'Why did we move [from Washington, D.C.] to Texas?' Well, we knew that this was a great philanthropic environment. So this is really very much a Texas vaccine," although there were other, smaller donors from all over the country.


    Hotez says that unlike the mRNA vaccines from Pfizer and Moderna, and the viral vector vaccine from Johnson & Johnson, protein subunit vaccines like CORBEVAX have a track record. So he and Bottazzi were relatively certain CORBEVAX would be safe and effective.


    "And it's cheap, a dollar, dollar fifty a dose," Hotez says. "You're not going to get less expensive than that."


    Clinical trials showed they were right to be confident CORBEVAX would work. An unpublished study conducted in India involving 3,000 volunteers found the vaccine to be 90% effective in preventing disease cause by the original COVID-19 virus strain and 80% against the delta variant. It's still being tested against omicron.


    But CORBEVAX is already entering the real world. Last month, the vaccine received emergency use authorization from regulators in India. An Indian vaccine manufacturer called Biological E Ltd is now making the vaccine. The company says it is producing 100 million doses per month and has already sold 300 million doses to the Indian government.


    "The real beauty of the CORBEVAX vaccine that Drs. Hotez and Bottazzi created is that intellectual property of this vaccine will be available to everybody," Keith Martin says. "So you can get manufacturers in Senegal, and South Africa and Latin America to be able to produce this particular vaccine."


    By contrast, the makers of Pfizer and Moderna, for example, are not sharing their recipe.


    One drawback to the CORBEVAX technology is that it can't be modified as quickly as mRNA vaccines can to adjust to new variants.


    That forces public health officials to make difficult choices.


    "Something which can be adapted the fastest versus something that can be adapted relatively quickly, but then more importantly can be manufactured at a large global capacity and at a cost of production which is much lower," says Prashant Yadav, senior fellow at at the Center for Global Development in Washington, D.C. The thought is some protection may better than no protection.


    Of course, the ideal vaccine would have both qualities, and Peter Hotez is at work trying to develop technologies that can do that.


    "There's no issue with pushing innovation," he says. "I think that's one of the really positive features of the U.S. vaccination program for COVID. The problem was it wasn't balanced with a portfolio or oldies but goodies."


    Hotez is hoping his oldie but goodie will usher in a brighter future for the world.

    Quote from JedRothwell

    Wyttenbach added a laughing face to the graph showing that the vast majority of suffering and dead people in Switzerland are unvaccinated. Apparently, he thinks the agony and death are hilarious.

    Jed I posted the real data and a reference to the original document. 40..50% of all deaths here are double vaxx during the last 2 months. What you show is a fake graph just published to cheat the population.

Subscribe to our newsletter

It's sent once a month, you can unsubscribe at anytime!

View archive of previous newsletters

* indicates required

Your email address will be used to send you email newsletters only. See our Privacy Policy for more information.

Our Partners

Supporting researchers for over 20 years
Want to Advertise or Sponsor LENR Forum?
CLICK HERE to contact us.